TRX2

TRX2 is a dietary supplement marketed for individuals with hair loss. It is manufactured and sold by Oxford BioLabs in the United Kingdom, marketed in 2011. TRX2 is a dietary supplement marketed for individuals with hair loss. It is manufactured and sold by Oxford BioLabs in the United Kingdom, marketed in 2011. The name TRX2 is said to be derived from the Ancient Greek word trichos, meaning hair and the number 2 stands for second generation. The proper word for hair in Ancient Greek is however thrix (θρίξ). TRX2 contains amino acids and vitamins. Its ingredients are L-carnitine, L-tartaric acid, potassium chloride, L-leucine, isoleucine, valine, nicotinic acid, and biotin. The product is a dietary supplement, not a drug, and hence it doesn't need to be approved by the U.S. Food and Drug Administration (FDA). TRX2 has been tested by Oxford Biolabs in a clinical study. In the study, 59 male and female volunteers showing signs of alopecia completed 18 months of therapy, receiving either TRX2 or a placebo.